Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 29 source : Www.biospace.com save search
Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference
Published: 2021-04-29 (Crawled : 20:00) - biospace.com/
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: -0.21%
H: 1.19%
C: -2.01%
conference health
NovaBay Pharmaceuticals to Hold First Quarter 2021 Conference Call on May 6
Published: 2021-04-29 (Crawled : 19:00) - biospace.com/
NBY | $0.0773 0.39% 0.0% 920K
|
Health Technology
|
| O: -1.86%
H: 4.33%
C: 4.15%
conference
Altimmune to Present at Upcoming Scientific Conferences
Published: 2021-04-29 (Crawled : 19:00) - biospace.com/
ALT | $7.095 -6.28% -6.69% 2.2M
|
Commercial Services
|
| O: 0.93%
H: 5.45%
C: 0.71%
conference presentation
Chimerix to Report First Quarter 2021 Financial Results and Provide an Operational Update on May 6, 2021
Published: 2021-04-29 (Crawled : 19:00) - biospace.com/
CMRX | $0.9033 -2.38% -2.44% 88K
|
Health Technology
|
| O: 3.8%
H: 0.0%
C: -3.23%
financial results results
BioXcel Therapeutics Launches “Boiling Point” Educational Campaign
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
BTAI | News | $2.7 -9.09% -10.0% 880K
|
Health Technology
|
| O: 0.66%
H: 0.5%
C: -1.03%
education therapeutics
Biopharma Companies Wrestle with Staffing Situations and Shortages from Pandemic
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.09%
C: -0.64%
biopharma
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: -1.34%
H: 0.51%
C: -4.75%
phase 2 positive
Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: -1.29%
presentation biotech iot
Merck Announces First-Quarter 2021 Financial Results
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -2.06%
H: 0.32%
C: -2.41%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.09%
C: -0.64%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: -1.22%
financial results results
Thermo Fisher Scientific Reports First Quarter 2021 Results
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -1.68%
H: 0.45%
C: -2.77%
results
Blueprint Medicines Reports First Quarter 2021 Financial Results
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
BPMC | $92.31 0.02% 0.02% 560K
|
Health Technology
|
| O: 3.98%
H: 0.64%
C: -2.23%
financial results results
BD Announces Enrollment in Post-Market Studies of the WavelinQ™ Arteriovenous Endovascular Fistula
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
BDX | $233.83 -0.23% 0.0% 770K
|
Health Technology
|
| O: 0.25%
H: 0.04%
C: -2.61%
enroll
Landos Biopharma Announces First Patient Dosed in a Phase 1b Study of NX-13 for Ulcerative Colitis
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
LABP | $22.21 0.27% 0.27% 9.1K
|
|
| O: 0.0%
H: 1.03%
C: -2.64%
biopharma phase 1 phase 1b phase 2b ulcerative colitis
Elucida Oncology Announces Three Key Additions to Its Board of Directors and the Appointment of Robert Essner as Chairman of the Board
Published: 2021-04-29 (Crawled : 17:00) - biospace.com/
UTHR | $237.06 1.11% 1.09% 610K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -0.49%
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: -3.47%
Insight Medbotics appoints new President & CEO
Published: 2021-04-29 (Crawled : 17:00) - biospace.com/
PROF | News | $7.85 -5.42% -5.73% 17K
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: -3.49%
ceo leo
Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin
Published: 2021-04-29 (Crawled : 17:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: -0.56%
H: 0.48%
C: -7.53%
Annovis Bio to Study Potential of ANVS401 to Normalize Brain Development in Down Syndrome
Published: 2021-04-29 (Crawled : 16:00) - biospace.com/
ANVS | $12.74 7.24% -2.04% 490K
|
Health Technology
|
| O: 1.56%
H: 0.13%
C: -4.0%
potential syndros anvs401 train
Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021
Published: 2021-04-29 (Crawled : 15:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.0%
H: 3.59%
C: 2.68%
financial results results conference
Bristol Myers Squibb Reports First Quarter Financial Results for 2021
Published: 2021-04-29 (Crawled : 15:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -1.56%
H: 0.4%
C: -3.25%
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
|
| O: 0.12%
H: 0.4%
C: -0.36%
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: 0.2%
H: 0.66%
C: -0.72%
financial results results
Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit
Published: 2021-04-29 (Crawled : 15:00) - biospace.com/
ACET | News | $1.87 -10.95% -12.3% 1.4M
|
Health Technology
|
| O: 3.75%
H: 1.97%
C: 1.61%
life science
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.